RESEARCH METHODOLOGY POSTER PRESENTATION ABSTRACTS
Please note: All posters will be displayed in
Salons 10-12.
FRIDAY, 10:15-11:00 AM
Merenstein D, Park H*.
Yogurt beverages as a vehicle to deliver high dose probiotics.
Georgetown University Djm23@georgetown.edu
*Presenting author
Probiotics are live microorganisms that, when administered
in sufficient amounts, may improve health. Yogurt, a fermented milk
product, is produced by the action of two probiotics, Lactobacillus
bulgaricus and Streptococcus thermophilus. In fact, two-thirds
of primary care physicians who counsel patients about nutrition recommend
consuming yogurt containing live active cultures (probiotics) for their
health benefit. Yogurt can be an effective delivery vehicle for probiotics,
but yogurts available in the United States are not formulated with attention
to optimal probiotic strains or dose. Yogurt is also an attractive delivery
agent because of its popularity with parents and children, likely improving
compliance over probiotic supplements. We propose to produce and evaluate
yogurt formulated with a probiotic strain at a dose that results in
recovery in stools. Our long-term goal is to develop yogurt with sufficient
probiotic dosages to positively impact several aspects of health. However,
evidence for these health outcomes is lacking. Our goals for this study
are: 1) to determine whether we can produce yogurt with proper probiotic
dosage that survives the gastrointestinal tract; and, 2) to conduct
pilot studies leading to effectiveness studies in the prevention of
antibiotic-associated diarrhea. We have three specific aims to accomplish
these goals. Aim #1: To produce drinkable yogurt that will supply 10x10
colony forming units of supplemental probiotics, Lactobacillus GG (LGG),
per day. Aim #2: To test LGG supplemented yogurt and placebo yogurt
(yogurt with only starter cultures) in a crossover style fashion in
children to determine if the supplemental probiotics survive the gastrointestinal
tract and are identifiable in stools. Aim #3: To evaluate the feasibility
of conducting randomized placebo-controlled clinical trials of yogurt,
we will conduct an open label pilot study with children. This proposal
is in consort with National Center for Complementary and Alternative
Medicine's mission and priorities designed to: 1) determine active ingredients,
pharmacology, bioavailability and optimal dosing; 2) identify surrogate
markers; and, 3) assess study feasibility. A yogurt will be produced
with more efficacious probiotic content at a dose that enables probiotic
survival through the intestinal tract as assessed by stool analysis.
Our rationale for using yogurt as a vehicle for transmission is that
it has the potential for much greater public health benefits than using
probiotics as medicinal supplements. A readily available yogurt with
high dose probiotics has the potential to greatly impact health throughout
the world.
Back